Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

High-Tech GründerfondsLatest May 7

Sedivention · €2.9M Seed brainjo · €2M Seed

6rounds

—led

Healthtech 5Biotech 1

Seed 5, Undisclosed 1

May 7, 2026

Details

New companies 6 · Follow-on 0

Stages: Seed 5, Undisclosed 1

Sedivention €2.9M Seed brainjo €2M Seed Cellbricks Therapeutics €10M Seed+Non-Dilutive

Qiming Venture PartnersLatest Apr 29

Vivacta Biotechnology · $50M Series A+Pulnovo Medical · $100M Strategic

6rounds

—led

Biotech 4Healthtech 2

Undisclosed 3, Series A 2, Series B 1

Apr 29, 2026

Details

New companies 5 · Follow-on 1

Stages: Undisclosed 3, Series A 2, Series B 1

Vivacta Biotechnology $50M Series A+Pulnovo Medical $100M Strategic Vivatides Therapeutics $54M Series A

Innovate UKLatest Oct 20

Emerald · £1.4M Grant and venture funding Stride · £4.6M Seed funding

5rounds

0led

Healthtech 5

Undisclosed 3, Pre-seed 1, Seed 1

Oct 20, 2026

Details

New companies 5 · Follow-on 0

Stages: Undisclosed 3, Pre-seed 1, Seed 1

Emerald £1.4M Grant and venture funding Stride £4.6M Seed funding Strolll £4.3M Innovate UK loan and grant package

First Round CapitalLatest Oct 7

Healthleap · $8M Seed Healia · $14M Series A

5rounds

1led

Healthtech 3Biotech 1Fintech 1

Series C+ 2, Seed 1, Series A 1, Undisclosed 1

Oct 7, 2026

Details

New companies 5 · Follow-on 0

Stages: Series C+ 2, Seed 1, Series A 1, Undisclosed 1

Healthleap $8M Seed Healia $14M Series A Corner Health $32.5M Seed+Series A

Eli Lilly and CompanyLatest Oct 6

General Medicine · $120M Series B Thatch · $108M New funding

5rounds

0led

Biotech 3Healthtech 2

Series B 2, Series A 1, Series C+ 1, Undisclosed 1

Oct 6, 2026

Details

New companies 5 · Follow-on 0

Stages: Series B 2, Series A 1, Series C+ 1, Undisclosed 1

General Medicine $120M Series B Thatch $108M New funding Leal Therapeutics $30M Series A

Emerson CollectiveLatest Oct 1

Devoted Health · $555M Series G Teal Health · $22M Series A

5rounds

0led

Healthtech 5

Series A 2, Series C+ 2, Seed 1

Oct 1, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Series C+ 2, Seed 1

Devoted Health $555M Series G Teal Health $22M Series A Throne Science $10M Series A

Bessemer Venture PartnersLatest Sep 29

EliseAI · $350M Growth financing Archy · $50M Series C

5rounds

2led

Healthtech 4AI 1

Series A 2, Series B 1, Series C+ 1, Undisclosed 1

Sep 29, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Series B 1, Series C+ 1, Undisclosed 1

EliseAI $350M Growth financing Archy $50M Series C Graph AI $13.3M Series A

SemperVirensLatest Sep 16

Thatch · $108M New funding Epsilon Health · $27.6M Funding

5rounds

0led

Healthtech 5

Series C+ 2, Undisclosed 2, Seed 1

Sep 16, 2026

Details

New companies 5 · Follow-on 0

Stages: Series C+ 2, Undisclosed 2, Seed 1

Thatch $108M New funding Epsilon Health $27.6M Funding Stepful $55M Series C

Catalio Capital ManagementLatest Sep 15

Evvy · $40M Series B AdvanCell · $315M Series D

5rounds

1led

Healthtech 4Biotech 1

Series B 2, Growth 1, Series C+ 1, Undisclosed 1

Sep 15, 2026

Details

New companies 5 · Follow-on 0

Stages: Series B 2, Growth 1, Series C+ 1, Undisclosed 1

Evvy $40M Series B AdvanCell $315M Series D 9amHealth $26M Series B

Labcorp Venture FundLatest Sep 15

Evvy · $40M Series B N-Power Medicine · $32M Series B

5rounds

0led

Healthtech 4Biotech 1

Series B 3, Undisclosed 2

Sep 15, 2026

Details

New companies 5 · Follow-on 0

Stages: Series B 3, Undisclosed 2

Evvy $40M Series B N-Power Medicine $32M Series B Vitestro $70M Series B

Oxford Science EnterprisesLatest Sep 15

ReEmerge, Inc. · $37M Series A Vivid Dx · $15M Seed

5rounds

0led

Healthtech 3AI 1Biotech 1

Seed 3, Series A 2

Sep 15, 2026

Details

New companies 5 · Follow-on 0

Stages: Seed 3, Series A 2

ReEmerge, Inc. $37M Series A Vivid Dx $15M Seed Mirae $5.4M Seed

CRVLatest Sep 14

Archy · $50M Series C Cradlewise · $12M Series A

5rounds

0led

Healthtech 4Consumer 1

Series A 4, Series C+ 1

Sep 14, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 4, Series C+ 1

Archy $50M Series C Cradlewise $12M Series A Joyful Health $17M Series A

Insight PartnersLatest Sep 11

Graph AI · $13.3M Series A Inspiren · $70M Series C

5rounds

1led

Healthtech 4Fintech 1

Series A 2, Series C+ 2, Growth 1

Sep 11, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Series C+ 2, Growth 1

Graph AI $13.3M Series A Inspiren $70M Series C TytoCare >$25M Growth

Gates FoundationLatest Aug 27

Readily Diagnostics · ~$970K Gates Foundation grant ProFound Therapeutics · $35M Strategic

5rounds

0led

Biotech 3Healthtech 2

Undisclosed 3, Series A 1, Series B 1

Aug 27, 2026

Details

New companies 5 · Follow-on 0

Stages: Undisclosed 3, Series A 1, Series B 1

Readily Diagnostics ~$970K Gates Foundation grant ProFound Therapeutics $35M Strategic Leyden Laboratories €40M Series B

Define VenturesLatest Aug 26

Arintra · $25M Series B Blank Bio · $7.2M Seed

5rounds

—led

Healthtech 4Biotech 1

Series B 3, Seed 1, Series C+ 1

Aug 26, 2026

Details

New companies 5 · Follow-on 0

Stages: Series B 3, Seed 1, Series C+ 1

Arintra $25M Series B Blank Bio $7.2M Seed 9amHealth $26M Series B

S3 VenturesLatest Aug 20

MaxQ Medical · $31.5M Series A Versa Vascular · $42M Series C

5rounds

—led

Healthtech 5

Series A 2, Series C+ 2, Series B 1

Aug 20, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Series C+ 2, Series B 1

MaxQ Medical $31.5M Series A Versa Vascular $42M Series C Advanced NanoTherapies >$31M Series B

Alexandria Venture InvestmentsLatest Aug 17

Leal Therapeutics · $30M Series A Khartis Therapeutics · $50M Series B

5rounds

—led

Biotech 5

Series A 2, Series B 2, Series C+ 1

Aug 17, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Series B 2, Series C+ 1

Leal Therapeutics $30M Series A Khartis Therapeutics $50M Series B Vedana Therapeutics $46M Series A

Sanofi VenturesLatest Aug 4

QuantHealth · $45M Series B AdvanCell · $315M Series D

5rounds

—led

Biotech 4Healthtech 1

Series A 3, Series B 1, Series C+ 1

Aug 4, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 3, Series B 1, Series C+ 1

QuantHealth $45M Series B AdvanCell $315M Series D Bionyra Pharma $165M Series A

Menlo VenturesLatest Jun 24

Assort Health · $120M Series C Nourish · $100M Series C

5rounds

—led

Healthtech 5

Series C+ 4, Series B 1

Jun 24, 2026

Details

New companies 5 · Follow-on 0

Stages: Series C+ 4, Series B 1

Assort Health $120M Series C Nourish $100M Series C Grow Therapy $150M Series D

Kleiner PerkinsLatest May 28

Garner Health · $100M Series E Health Universe · $6M Seed

5rounds

—led

Healthtech 5

Series C+ 3, Seed 1, Series A 1

May 28, 2026

Details

New companies 4 · Follow-on 1

Stages: Series C+ 3, Seed 1, Series A 1

Garner Health $100M Series E Health Universe $6M Seed Garner Health $118M Series D

Oncology VenturesLatest May 28

Triomics · $22M Series B Modicus Prime · $4.5M Undisclosed

5rounds

—led

Healthtech 3AI 1Biotech 1

Series A 2, Undisclosed 2, Series B 1

May 28, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Undisclosed 2, Series B 1

Triomics $22M Series B Modicus Prime $4.5M Undisclosed NexCure $19M Series A

Maverick VenturesLatest May 19

Nourish · $100M Series C Chapter · $100M Series E

5rounds

—led

Healthtech 5

Series C+ 3, Seed 1, Series A 1

May 19, 2026

Details

New companies 5 · Follow-on 0

Stages: Series C+ 3, Seed 1, Series A 1

Nourish $100M Series C Chapter $100M Series E Daffodil Health $16.3M Series A

Santé VenturesLatest Apr 15

Sonire Therapeutics · $18M Series A Endovascular Engineering · $80M Series C

5rounds

—led

Healthtech 5

Series A 2, Seed 1, Series C+ 1, Undisclosed 1

Apr 15, 2026

Details

New companies 5 · Follow-on 0

Stages: Series A 2, Seed 1, Series C+ 1, Undisclosed 1

Sonire Therapeutics $18M Series A Endovascular Engineering $80M Series C beHuman $4M Seed

Bling CapitalLatest Oct 15

Sunbound · $24M Series A Novellia · $18M Series A

4rounds

0led

Healthtech 3Fintech 1

Series A 2, Seed 1, Series C+ 1

Oct 15, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Seed 1, Series C+ 1

Sunbound $24M Series A Novellia $18M Series A Village $9.5M Seed

Healthier CapitalLatest Oct 13

Suki · $90M Series E Photon · $16M Series A

4rounds

0led

Healthtech 4

Series A 2, Series B 1, Series C+ 1

Oct 13, 2026

Details

New companies 4 · Follow-on 0

Stages: Series A 2, Series B 1, Series C+ 1

Suki $90M Series E Photon $16M Series A Qualified Health $125M Series B

AtomicoLatest Oct 12

Scarlet · $50M Series B Neko Health · $700M Series C

4rounds

0led

Healthtech 4

Series C+ 2, Seed 1, Series B 1

Oct 12, 2026

Details

New companies 4 · Follow-on 0

Stages: Series C+ 2, Seed 1, Series B 1

Scarlet $50M Series B Neko Health $700M Series C Frontier Health £9.7M Seed

Entrepreneurs FirstLatest Oct 12

Scarlet · $50M Series B Juno Bio · $3.8M Seed

4rounds

0led

Healthtech 4

Seed 3, Series B 1

Oct 12, 2026

Details

New companies 4 · Follow-on 0

Stages: Seed 3, Series B 1

Scarlet $50M Series B Juno Bio $3.8M Seed Uncovr $7M Seed

UPMC EnterprisesLatest Sep 29

ai3Bio · $48M Series A RAAPID · Undisclosed Strategic

4rounds

1led

Healthtech 3Biotech 1

Series A 3, Undisclosed 1

Sep 29, 2026

Details

New companies 3 · Follow-on 1

Stages: Series A 3, Undisclosed 1

ai3Bio $48M Series A RAAPID Undisclosed Strategic RAAPID Undisclosed Series A+

InvusLatest Sep 24

Precision Neuroscience · $250M Series D LifeMine Therapeutics · $263M Series D+Series E

4rounds

0led

Biotech 3Healthtech 1

Series B 2, Series C+ 1, Undisclosed 1

Sep 24, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Series C+ 1, Undisclosed 1

Precision Neuroscience $250M Series D LifeMine Therapeutics $263M Series D+Series E City Therapeutics $99.5M Series B

Mubadala CapitalLatest Sep 24

Precision Neuroscience · $250M Series D Ollin Biosciences · $330M Series B

4rounds

0led

Biotech 3Healthtech 1

Series B 2, Series C+ 2

Sep 24, 2026

Details

New companies 4 · Follow-on 0

Stages: Series B 2, Series C+ 2

Precision Neuroscience $250M Series D Ollin Biosciences $330M Series B Alloy Therapeutics $40M Series E

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.